Terms: = Colorectal cancer AND HSP90AA1, ENSG00000080824, 3320, P07900, LAP2, HSPN, HSPCAL4, HSPCAL1, HSPCA, HSPC1, HSP90N, HSP90A, Hsp90, Hsp89, HSP86, FLJ31884 AND Treatment
102 results:
1. MYG1 drives glycolysis and colorectal cancer development through nuclear-mitochondrial collaboration.
Chen J; Duan S; Wang Y; Ling Y; Hou X; Zhang S; Liu X; Long X; Lan J; Zhou M; Xu H; Zheng H; Zhou J
Nat Commun; 2024 Jun; 15(1):4969. PubMed ID: 38862489
[TBL] [Abstract] [Full Text] [Related]
2. Exploring active ingredients and mechanisms of Coptidis Rhizoma-ginger against colon cancer using network pharmacology and molecular docking.
Zeng T; Ling C; Liang Y
Technol Health Care; 2024; 32(S1):523-542. PubMed ID: 38759074
[TBL] [Abstract] [Full Text] [Related]
3. Discovery of a novel small-molecule activator of SIRT3 that inhibits cell proliferation and migration by apoptosis and autophagy-dependent cell death pathways in colorectal cancer.
Mou Y; Chen Y; Fan Z; Ye L; Hu B; Han B; Wang G
Bioorg Chem; 2024 May; 146():107327. PubMed ID: 38579616
[TBL] [Abstract] [Full Text] [Related]
4. Prediction of potential mechanisms of rhubarb therapy for colorectal cancer based on network pharmacological analysis and molecular docking.
Yang F; Li X; Zhang Y; Ren Y; Zhang J; Xiao K
Medicine (Baltimore); 2024 Mar; 103(12):e37477. PubMed ID: 38518016
[TBL] [Abstract] [Full Text] [Related]
5. Light-enhanced VEGF
Longva AS; Berg K; Weyergang A
Front Immunol; 2023; 14():1278000. PubMed ID: 38173721
[TBL] [Abstract] [Full Text] [Related]
6.
Jung EJ; Kim HJ; Shin SC; Kim GS; Jung JM; Hong SC; Kim CW; Lee WS
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139333
[TBL] [Abstract] [Full Text] [Related]
7. Inhibition of TRAP1 Accelerates the DNA Damage Response, Activation of the Heat Shock Response and Metabolic Reprogramming in Colon cancer Cells.
Bhasin N; Dabral P; Senavirathna L; Pan S; Chen R
Front Biosci (Landmark Ed); 2023 Sep; 28(9):227. PubMed ID: 37796715
[TBL] [Abstract] [Full Text] [Related]
8. Deactivation of glycogen synthase kinase-3β by heat shock‑inducible tumor small protein attenuates hyperthermia‑induced pro‑migratory activity in colorectal cancer cells.
Koizumi K; Domoto T; Minamoto T; Satomura K; Nakajima H
Int J Oncol; 2023 Aug; 63(2):. PubMed ID: 37387443
[TBL] [Abstract] [Full Text] [Related]
9. Research on the Regulatory Mechanism of Ginseng on the Tumor Microenvironment of colorectal cancer based on Network Pharmacology and Bioinformatics Validation.
Wang T; Zhang W; Fang C; Wang N; Zhuang Y; Gao S
Curr Comput Aided Drug Des; 2024; 20(5):486-500. PubMed ID: 37287284
[TBL] [Abstract] [Full Text] [Related]
10. LncRNA NNT-AS1/hsa-miR-485-5p/hsp90 axis in-silico and clinical prospect correlated-to histologic grades-based CRC stratification: A step toward ncRNA Precision.
El-Sheikh NM; Abulsoud AI; Fawzy A; Wasfey EF; Hamdy NM
Pathol Res Pract; 2023 Jul; 247():154570. PubMed ID: 37244051
[TBL] [Abstract] [Full Text] [Related]
11. Heat shock protein 90 (hsp90) inhibitors in gastrointestinal cancer: where do we currently stand?-A systematic review.
Magyar CTJ; Vashist YK; Stroka D; Kim-Fuchs C; Berger MD; Banz VM
J Cancer Res Clin Oncol; 2023 Aug; 149(10):8039-8050. PubMed ID: 36966394
[TBL] [Abstract] [Full Text] [Related]
12. Native Size-Exclusion Chromatography-Based Mass Spectrometry Reveals New Components of the Early Heat Shock Protein 90 Inhibition Response Among Limited Global Changes.
Samant RS; Batista S; Larance M; Ozer B; Milton CI; Bludau I; Wu E; Biggins L; Andrews S; Hervieu A; Johnston HE; Al-Lazikhani B; Lamond AI; Clarke PA; Workman P
Mol Cell Proteomics; 2023 Feb; 22(2):100485. PubMed ID: 36549590
[TBL] [Abstract] [Full Text] [Related]
13. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
[TBL] [Abstract] [Full Text] [Related]
14. Excessive HSP70/TLR2 activation leads to remodeling of the tumor immune microenvironment to resist chemotherapy sensitivity of mFOLFOX in colorectal cancer.
Feng H; Guo Z; Chen X; Liu K; Li H; Jia W; Wang C; Luo F; Ji X; Zhang T; Zhao R; Cheng X
Clin Immunol; 2022 Dec; 245():109157. PubMed ID: 36244673
[TBL] [Abstract] [Full Text] [Related]
15. Metabolic targeting of NRF2 potentiates the efficacy of the TRAP1 inhibitor G-TPP through reduction of ROS detoxification in colorectal cancer.
Tsai HY; Bronner MP; March JK; Valentine JF; Shroyer NF; Lai LA; Brentnall TA; Pan S; Chen R
Cancer Lett; 2022 Nov; 549():215915. PubMed ID: 36113636
[TBL] [Abstract] [Full Text] [Related]
16. Network Pharmacology and Molecular Docking Validation to Reveal the Pharmacological Mechanisms of Kangai Injection against colorectal cancer.
Zheng BB; Wang Q; Yue Y; Li J; Li XJ; Wang X
Biomed Res Int; 2022; 2022():3008842. PubMed ID: 36046463
[TBL] [Abstract] [Full Text] [Related]
17. DAB2IP down-regulates hsp90aa1 to inhibit the malignant biological behaviors of colorectal cancer.
Zhang M; Peng Y; Yang Z; Zhang H; Xu C; Liu L; Zhao Q; Wu J; Wang H; Liu J
BMC Cancer; 2022 May; 22(1):561. PubMed ID: 35590292
[TBL] [Abstract] [Full Text] [Related]
18. hsp90 inhibition acts synergistically with heat to induce a pro-immunogenic form of cell death in colon cancer cells.
Mouratidis PXE; Ter Haar G
Int J Hyperthermia; 2021; 38(1):1443-1456. PubMed ID: 34612127
[TBL] [Abstract] [Full Text] [Related]
19. TAS-116 (Pimitespib), an Oral hsp90 Inhibitor, in Combination with Nivolumab in Patients with colorectal cancer and Other Solid Tumors: An Open-Label, Dose-Finding, and Expansion Phase Ib Trial (EPOC1704).
Kawazoe A; Itahashi K; Yamamoto N; Kotani D; Kuboki Y; Taniguchi H; Harano K; Naito Y; Suzuki M; Fukutani M; Higuchi T; Ikeno T; Wakabayashi M; Sato A; Koyama S; Nishikawa H; Shitara K
Clin Cancer Res; 2021 Dec; 27(24):6709-6715. PubMed ID: 34593531
[TBL] [Abstract] [Full Text] [Related]
20. Predictive value of red blood cell distribution width level on histological response and prognosis in colorectal liver metastases.
Chen Q; Chen J; Deng Y; Huang Z; Zhao H; Cai J
Ann Palliat Med; 2021 Sep; 10(9):9383-9397. PubMed ID: 34498473
[TBL] [Abstract] [Full Text] [Related]
[Next]
